Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer.

[1]  D. Wood,et al.  Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  P F Sharp,et al.  Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Folpe,et al.  (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  D. Mankoff,et al.  Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors. , 2000, Neoplasia.

[5]  S. Larson,et al.  Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. , 1999, American journal of surgery.

[6]  W C Eckelman,et al.  Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture. , 1999, Cancer research.

[7]  C. Ling,et al.  Changes in FDG Tumor Uptake during and after Fractionated Radiation Therapy in a Rodent Tumor Xenograft. , 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[8]  J. Bertino,et al.  Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi‐mutated herpes simplex virus type‐1 (G207) , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  R L Wahl,et al.  Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  D. Lee,et al.  Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  P. Merlet,et al.  Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  H. Sakahara,et al.  FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  Y. Koide,et al.  Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  H. Yagata,et al.  Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2‐deoxy‐2‐fluoro[18F]‐D‐glucose , 1998, Cancer.

[15]  C. Degueldre,et al.  Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  S M Larson,et al.  Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding , 1997, Cancer.

[17]  H. Minn,et al.  Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  Mark A. Stephenson,et al.  Overexpression of glut1 and glut3 in stage I nonsmall cell lung carcinoma is Associated with poor survival , 1997, Cancer.

[19]  H. Müller-Gärtner,et al.  FDG-PET evaluation of retroperitoneal metastases of testicular cancer before and after chemotherapy. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  M. Fulham,et al.  The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. , 1996, Archives of surgery.

[21]  R L Wahl,et al.  Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  Saroj P. Mathupala,et al.  Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase. , 1996, Cancer research.

[23]  I. Leav,et al.  The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor models. , 1996, Nuclear medicine and biology.

[24]  M. Younes,et al.  Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. , 1996, Cancer research.

[25]  J. Gilsbach,et al.  PET-study of intracranial meningiomas: correlation with histopathology, cellularity and proliferation rate. , 1996, Acta neurochirurgica. Supplement.

[26]  W. Chapman,et al.  Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. , 1996, American journal of surgery.

[27]  R. Brown,et al.  GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. , 1995, Anticancer research.

[28]  S. Winawer,et al.  High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  D. Mayer,et al.  Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages. , 1994, Biochimica et biophysica acta.

[30]  L. Mortelmans,et al.  Clinical value of whole‐body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer , 1994, The British journal of surgery.

[31]  G. van Kaick,et al.  FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. , 1994, Nuclear medicine and biology.

[32]  T G Turkington,et al.  Performance characteristics of a whole-body PET scanner. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  S. Winawer,et al.  Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[34]  M. Ozaki,et al.  Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  J. Itami,et al.  Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  T. Kato,et al.  Recurrent rectal cancer and scar: differentiation with PET and MR imaging. , 1992, Radiology.

[37]  R L Wahl,et al.  Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. , 1991, Radiology.

[38]  J. Wilson,et al.  Complete amino acid sequence of the type II isozyme of rat hexokinase, deduced from the cloned cDNA: comparison with a hexokinase from novikoff ascites tumor. , 1991, Archives of biochemistry and biophysics.

[39]  J. Flier,et al.  Regulation of Glucose-Transporter Gene Expression In Vitro and In Vivo , 1990, Diabetes Care.

[40]  M. Birnbaum,et al.  Growth factors rapidly induce expression of the glucose transporter gene. , 1988, The Journal of biological chemistry.

[41]  Heikki Joensuu,et al.  Florodeoxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors , 1988 .

[42]  P. Pedersen,et al.  Purification and characterization of a bindable form of mitochondrial bound hexokinase from the highly glycolytic AS-30D rat hepatoma cell line. , 1988, Cancer research.

[43]  S. Larson,et al.  Metabolic imaging of human extremity musculoskeletal tumors by PET. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[44]  H. Minn,et al.  Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. , 1988, Cancer.

[45]  G. di Chiro,et al.  Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study. , 1987, Radiology.

[46]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[47]  G. Weber.  Enzymology of cancer cells (second of two parts). , 1977, The New England journal of medicine.

[48]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[49]  T. Sugimura,et al.  Hexokinase isozyme patterns of human uterine tumors , 1972, Cancer.

[50]  S. Jamdar,et al.  Hexokinase, differentiation and growth rates of transplanted rat tumors. , 1970, Cancer research.

[51]  Hans Ulrich Bergmeyer,et al.  Methods of Enzymatic Analysis , 2019 .

[52]  H. Morris,et al.  COMPARATIVE BIOCHEMISTRY HEPATOMAS. IV. ISOTOPE STUDIES OF GLUCOSE AND FRUCTOSE METABOLISM IN LIVER TUMORS OF DIFFERENT GROWTH RATES. , 1963, Cancer research.

[53]  H. Morris,et al.  COMPARATIVE BIOCHEMISTRY OF HEPATOMAS. III. CARBOHYDRATE ENZYMES IN LIVER TUMORS OF DIFFERENT GROWTH RATES. , 1963, Cancer research.

[54]  H. Morris,et al.  COMPARATIVE BIOCHEMISTRY OF HEPATOMAS. V. STUDIES ON AMINO ACID INCORPORATION IN LIVER TUMORS OF DIFFERENT GROWTH RATES. , 1963, Cancer research.

[55]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[56]  G. Weber,et al.  Glucose-6-phosphatase activity in normal, pre-cancerous, and neoplastic tissues. , 1955, Cancer research.